Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Lymphoid 1

Conditions

Multiple Myeloma 145Lymphoma, Follicular 41Lymphoma, Large B-Cell, Diffuse 36Lymphoma, B-Cell, Marginal Zone 24Recurrence 17Lymphoma, Mantle-Cell 17Lymphoma 16Neoplasms, Plasma Cell 15Lymphoma, Non-Hodgkin 15Leukemia, Lymphocytic, Chronic, B-Cell 11Neoplasms 9Lymphoma, B-Cell 8Smoldering Multiple Myeloma 7Burkitt Lymphoma 5Neoplasm, Residual 4Leukemia, Plasma Cell 4Waldenstrom Macroglobulinemia 3Myelodysplastic Syndromes 3Lymphoma, T-Cell, Peripheral 3Lymphoma, T-Cell, Cutaneous 3Plasmacytoma 2Pancreatic Neoplasms 2Neuroblastoma 2Lymphoma, T-Cell 2Leukemia, Myelomonocytic, Chronic 2Leukemia, Myeloid, Acute 2Leukemia 2Hodgkin Disease 2Hematologic Diseases 2Urinary Bladder Neoplasms 1

Interventions

Cyclophosphamide 9glofitamab 4Whole-Body Irradiation 4Rituximab 4fludarabine phosphate 3fludarabine 3Mycophenolic Acid 3Melphalan 3Doxorubicin 3polatuzumab vedotin 2pirtobrutinib 2pembrolizumab 2obinutuzumab 2Tacrolimus 2Sirolimus 2Prednisone 2Busulfan 2zanubrutinib 1venetoclax 1relmacabtagene autoleucel 1pegfilgrastim 1axicabtagene ciloleucel 1Vincristine 1Triamcinolone 1Specimen Handling 1Receptors, Chimeric Antigen 1Prednisolone 1Peripheral Blood Stem Cell Transplantation 1Oxaliplatin 1Methotrexate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Dendritic Cell Sarcoma, Interdigitating × Lenalidomide × 1 year × Clear all
NCT06220032 2026-01-05

HO170DLBCL

Stichting Hemato-Oncologie voor Volwassenen Nederland

Phase 3 Recruiting
324 enrolled
LymphoidSarcoma

Heart Failure, Lymphoma, Large B-Cell, Diffuse, Dendritic Cell Sarcoma, Interdigitating, Cardiotoxicity

Data powered by HemOnc (CC BY 4.0) Colophon âš¡